Alainna J Jamal1, Felipe Garcia-Jeldes2, Mahin Baqi3, Sergio Borgia3, Jennie Johnstone2, Kevin Katz4, Philipp Kohler2, Matthew P Muller1, Allison J McGeer1. 1. Institute of Health Policy, Management and Evaluation,University of Toronto,Toronto, Ontario,Canada. 2. Department of Infection Control,Sinai Health System,Toronto, Ontario,Canada. 3. Department of Infection Prevention and Control,William Osler Health Center,Brampton, Ontario,Canada. 4. Department of Infection Prevention and Control,North York General Hospital,Toronto, Ontario,Canada.
Abstract
OBJECTIVE: To determine infection prevention and control (IPAC) practices for carbapenemase-producing Enterobacteriaceae (CPE), an emerging threat, at acute-care hospitals in Ontario, Canada. DESIGN: A descriptive cross-sectional survey. METHODS: We surveyed IPAC directors and managers at all acute-care hospitals in Ontario, Canada, to gather information on IPAC practices related to CPE, including admission screening, other patient screening, environmental testing, use of precautions to prevent transmission, and outbreak management. RESULTS: Of 116 acute-care hospitals, 105 (91%) responded. Admission screening included patients previously colonized or infected with CPE (n = 64, 61%), patients recently hospitalized outside of Canada (Indian subcontinent, n = 62, 59%; other countries, n = 56, 53%), and patients recently hospitalized in Canada (n = 22, 21%). Fifty-one hospitals (49%) screened patients for colonization during an outbreak. Almost all hospitals (n = 101, 96%) used precautions to prevent transmission from patients with CPE colonization or infection; most hospitals (n = 54, 53%) continued precautions indefinitely. Few hospitals (n = 19, 18%) performed environmental cultures. Eight hospitals (8%) reported at least 1 outbreak, and 6 hospitals (6%) reported transmission from sink or shower drains to patients. CONCLUSIONS: Variability in practices may result from lack of evidence and challenges in updating guidelines as evidence emerges. A coordinated approach to slow the emergence of CPE should be considered in our population.
OBJECTIVE: To determine infection prevention and control (IPAC) practices for carbapenemase-producing Enterobacteriaceae (CPE), an emerging threat, at acute-care hospitals in Ontario, Canada. DESIGN: A descriptive cross-sectional survey. METHODS: We surveyed IPAC directors and managers at all acute-care hospitals in Ontario, Canada, to gather information on IPAC practices related to CPE, including admission screening, other patient screening, environmental testing, use of precautions to prevent transmission, and outbreak management. RESULTS: Of 116 acute-care hospitals, 105 (91%) responded. Admission screening included patients previously colonized or infected with CPE (n = 64, 61%), patients recently hospitalized outside of Canada (Indian subcontinent, n = 62, 59%; other countries, n = 56, 53%), and patients recently hospitalized in Canada (n = 22, 21%). Fifty-one hospitals (49%) screened patients for colonization during an outbreak. Almost all hospitals (n = 101, 96%) used precautions to prevent transmission from patients with CPE colonization or infection; most hospitals (n = 54, 53%) continued precautions indefinitely. Few hospitals (n = 19, 18%) performed environmental cultures. Eight hospitals (8%) reported at least 1 outbreak, and 6 hospitals (6%) reported transmission from sink or shower drains to patients. CONCLUSIONS: Variability in practices may result from lack of evidence and challenges in updating guidelines as evidence emerges. A coordinated approach to slow the emergence of CPE should be considered in our population.
Authors: Alainna J Jamal; Amna Faheem; Lubna Farooqi; Xi Zoe Zhong; Irene Armstrong; David A Boyd; Emily Borgundvaag; Brenda L Coleman; Karen Green; Kithsiri Jayasinghe; Jennie Johnstone; Kevin Katz; Philipp Kohler; Angel X Li; Laura Mataseje; Roberto Melano; Matthew P Muller; Michael R Mulvey; Sarah Nayani; Samir N Patel; Aimee Paterson; Susan Poutanen; Anu Rebbapragada; David Richardson; Alicia Sarabia; Shumona Shafinaz; Andrew E Simor; Barbara M Willey; Laura Wisely; Allison J McGeer Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Sarah Rehou; Sydney Rotman; Melisa Avaness; Natasha Salt; Marc G Jeschke; Shahriar Shahrokhi Journal: J Burn Care Res Date: 2022-09-01 Impact factor: 1.819
Authors: Alainna J Jamal; Laura F Mataseje; Victoria Williams; Jerome A Leis; Nathalie Tijet; Sandra Zittermann; Roberto G Melano; Michael R Mulvey; Kevin Katz; Vanessa G Allen; Allison J McGeer Journal: Antimicrob Agents Chemother Date: 2021-07-16 Impact factor: 5.191
Authors: Ekaterina S Kuzina; Tatiana S Novikova; Evgeny I Astashkin; Galina N Fedyukina; Angelina A Kislichkina; Natalia V Kurdyumova; Ivan A Savin; Olga N Ershova; Nadezhda K Fursova Journal: Antibiotics (Basel) Date: 2022-07-03